Gut Priming With Oral Bovine Colostrum for Preterm Neonates; Randomized Control Trial
Effect of Bovine Colostrum On T-Regulatory Cells, Prevention Of Late Onset Sepsis And Necrotizing Enterocolitis In Preterm Neonates
1 other identifier
interventional
80
1 country
1
Brief Summary
The aim was to assess the ability of bovine colostrum concentrate to reduce the incidence of late-onset sepsis episodes and necrotizing enterocolitis in artificially fed preterm neonates and its effect on T regulatory cells. And to evaluate the effect of bovine colostrum concentrate on feeding tolerance, growth, hospital stay and mortality in preterm neonates.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 15, 2018
CompletedFirst Submitted
Initial submission to the registry
November 8, 2018
CompletedFirst Posted
Study publicly available on registry
April 24, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 15, 2019
CompletedJune 23, 2020
June 1, 2020
9 months
November 8, 2018
June 21, 2020
Conditions
Outcome Measures
Primary Outcomes (3)
Incidence of Late Onset Sepsis in the three groups
Incidence of Late Onset Sepsis in the studied group measured by rodwell and tollner sepsis scoring system
From time of randomization to discharge from nicu or death whichever comes first
The incidence of Necrotizing Enterocolitis in the three groups
Incidence of Necrotizing Enterocolitis in the three groups diagnosed according to bell's staging
From time of randomization to discharge from nicu or death whichever comes first
The change of Active T regulatory cells In the three groups
Active T regulatory cells diagnosed by cell CD 4 expressing CD 25 high or simultaneously CD 25 plus FOXP3
Change from base line at randomization and after intervention by 1 week
Secondary Outcomes (3)
Feeding intolerance is defined as presence of at least 3 consecutive days of any of the following:emesis, gastric residuals, diarrhea, blood in stools or abnormally enlarged bowel loops
From time of randomization to discharge from nicu or death whichever comes first
Neonatal mortality
From time of randomization to discharge from nicu or death whichever comes first
Duration of hospital stay
From time of randomization to discharge from nicu or death whichever comes first
Study Arms (2)
Non bovine colostrun
NO INTERVENTIONPreterm received preterm formula
Bovine colostrum group
ACTIVE COMPARATORPreterm received bovine colostrum as trophic feeding
Interventions
Eligibility Criteria
You may qualify if:
- Preterm Neonate having a gestational age equal or less than 34 weeks at birth, admitted in Ain-Shams University NICUs
You may not qualify if:
- Maternal risk factor of early onset sepsis, chorioamnionitis.
- Proved early onset sepsis.
- Life-threatening congenital abnormalities.
- Inborn error of metabolism.
- Chromosomal aberrations.
- Neonates with underlying gastrointestinal problems (such as GIT anomalies) that prevent enteral feeding.
- Perinatal asphyxia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medicin
Giza, Abasseya, 05000, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hisham Awad
professor of pediatrics Ain Shams university
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical professor
Study Record Dates
First Submitted
November 8, 2018
First Posted
April 24, 2019
Study Start
September 15, 2018
Primary Completion
June 15, 2019
Study Completion
September 15, 2019
Last Updated
June 23, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share
research protocol